Enzo Biochem (ENZ) Reports In-Line Q2 EPS

Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $24.2 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ennis (EBF) Reports In-Line Q1 EPS
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance